  Breast cancer is one of the leading causes of cancer mortality. Breast cancer
patients in developing countries, especially sub-Saharan Africa, South Asia,
and South America, suffer from the highest mortality rate in the world. One
crucial factor contributing to the global disparity in mortality rate is long
delay of diagnosis due to a severe shortage of trained pathologists, which
consequently has led to a large proportion of late-stage presentation at
diagnosis. The delay between the initial development of symptoms and the
receipt of a diagnosis could stretch upwards 15 months. To tackle this critical
healthcare disparity, this research has developed a deep learning-based
diagnosis system for metastatic breast cancer that can achieve high diagnostic
accuracy as well as computational efficiency. Based on our evaluation, the
MobileNetV2-based diagnostic model outperformed the more complex VGG16,
ResNet50 and ResNet101 models in diagnostic accuracy, model generalization, and
model training efficiency. The visual comparisons between the model prediction
and ground truth have demonstrated that the MobileNetV2 diagnostic models can
identify very small cancerous nodes embedded in a large area of normal cells
which is challenging for manual image analysis. Equally Important, the light
weighted MobleNetV2 models were computationally efficient and ready for mobile
devices or devices of low computational power. These advances empower the
development of a resource-efficient and high performing AI-based metastatic
breast cancer diagnostic system that can adapt to under-resourced healthcare
facilities in developing countries. This research provides an innovative
technological solution to address the long delays in metastatic breast cancer
diagnosis and the consequent disparity in patient survival outcome in
developing countries.
